Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
Paolo Andrea Zucali(Humanitas University), Giuseppe Giaccone(Cornell University)
Cited by 88
Related Papers
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
|Journal of Clinical Oncology|2004|1.7k
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2009|913
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
|PubMed|2002|507
Classification of current anticancer immunotherapies
|Oncotarget|2014|469